Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH MM 2018 | Judging the value of a clinical trial in hem-onc

Robert Hills • 5 Oct 2018
ESH MM 2018
General Gemtuzumab ozogamicin
ALFA 0701

The results of clinical trials are open to interpretation and are dependent upon a vast array of factors, including cohort size, the endpoints chosen and the statistics used to analyze the resulting date. Here, Robert Hills from the University of Oxford, Oxford, UK, discusses the most important considerations when judging the value of a clinical trial. This video was recorded at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.

More from Robert Hills

UK NCRI AML17 trial update: everolimus addition for consolidation
2:05
UK NCRI AML17 trial update: everolimus addition for consolidation
Robert Hills • 5 Oct 2018
Opinion: value of MRD as an endpoint in hem-onc clinical trials
2:17
Opinion: value of MRD as an endpoint in hem-onc clinical trials
Robert Hills • 5 Oct 2018

Related Videos

Combining isatuximab, lenalidomide, oral cyclophosphamide, & dexamethasone for HR smoldering myeloma
4:53
Combining isatuximab, lenalidomide, oral cyclophosphamide, & dexamethasone for HR smoldering myeloma
Maher Salamoon • 9 Sep 2026
Treating peripheral T-cell lymphoma with chemotherapy, avelumab and brentuximab vedotin
4:17
Treating peripheral T-cell lymphoma with chemotherapy, avelumab and brentuximab vedotin
Maher Salamoon • 9 Sep 2026
Insights into the risk of pulmonary infections in patients with CLL treated with targeted agents
5:31
Insights into the risk of pulmonary infections in patients with CLL treated with targeted agents
Maher Salamoon • 8 Sep 2026
Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals